Blockade of Extracellular Regulated Kinase 1/2 (ERK1/2) Alters Antinociception and Tolerance to Damgo, but Not to Fentanyl

Authors

Erin N. Bobeck, Utah State UniversityFollow
Susan L. Ingram, Oregon Health & Science University
Michael M. Morgan, Washington State University Vancouver

Document Type

Poster

Journal/Book Title/Conference

Experimental Biology

Location

Boston, MA

Publication Date

1-1-2013

Recommended Citation

Bobeck, E.N., Ingram, S.L., & Morgan, M.M. (2013) Blockade of Extracellular Regulated Kinase 1/2 (ERK1/2) Alters Antinociception and Tolerance to Damgo, but Not to Fentanyl. Experimental Biology. Boston, MA.